S&P 500
(0.91%) 5 064.20 points
Dow Jones
(0.85%) 38 226 points
Nasdaq
(1.51%) 15 841 points
Oil
(-0.03%) $78.98
Gas
(5.33%) $2.04
Gold
(0.13%) $2 313.90
Silver
(0.58%) $26.90
Platinum
(0.80%) $962.55
USD/EUR
(-0.08%) $0.932
USD/NOK
(-0.36%) $10.99
USD/GBP
(-0.12%) $0.798
USD/RUB
(-1.36%) $91.99

Realaus laiko atnaujinimai SANUWAVE Health, Inc. [SNWV]

Birža: PNK Pramonė: Medical Devices
Atnaujinta2 geg. 2024 @ 22:21

15.00% $ 0.0230

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 22:21):

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally...

Stats
Šios dienos apimtis 610 125
Vidutinė apimtis 334 783
Rinkos kapitalizacija 26.23M
EPS $0 ( 2024-04-01 )
Kita pelno data ( $0 ) 2024-05-10
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.770
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2024-04-01 Sorensen Peter Buy 0
2023-12-30 Manchester Management Co Llc Buy 0 Future Advance Convertible Promissory Note
2023-12-30 Manchester Management Co Llc Buy 2 500 000 Common Stock Purchase Warrant
2023-12-30 Manchester Management Co Llc Buy 2 500 000 Common Stock Purchase Warrant
2023-12-30 Manchester Management Co Llc Buy 2 500 000 Common Stock Purchase Warrant
INSIDER POWER
88.34
Last 94 transactions
Buy: 194 230 063 | Sell: 31 191 675

SANUWAVE Health, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

SANUWAVE Health, Inc. Finansinės ataskaitos

Annual 2023
Pajamos: $20.40M
Bruto pelnas: $13.61M (66.73 %)
EPS: $-0.0325
FY 2023
Pajamos: $20.40M
Bruto pelnas: $13.61M (66.73 %)
EPS: $-0.0325
FY 2022
Pajamos: $16.74M
Bruto pelnas: $12.41M (74.13 %)
EPS: $-0.0187
FY 2021
Pajamos: $13.01M
Bruto pelnas: $8.02M (61.68 %)
EPS: $-0.0720

Financial Reports:

No articles found.

SANUWAVE Health, Inc.

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.